With respect to ADT duration, we found that patients who underwent < 12 months of concurrent ADT showed poorer 5-year BCR-free survival than patients who underwent longer-term (≥12 months) ADT, although the difference failed to reach statistical significance ( p = 0.232; Appendix ).
← all excerpts
Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study.
1
0.2320
0.2320